Share of capital allocation among big biotechs in U.S. and Europe by type 2014-2019
M&A activity accounted for 39 percent of the total capital allocation among big biotechs in 2019, versus share repurchases which accounted for 13 percent of total capital allocation. The statistic illustrates the distribution of capital allocation among big biotechs in the U.S. and Europe, between 2014 and 2019, by type of activity.